Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -410.23% is 74% above its 1-year average of -1608.23%, near the high end of its 1-year range (-5591.97%–0.00%).
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -752.93%.
OPERATING MARGIN
-410.23%
OPERATING MARGIN AVG TTM
N/A
OPERATING MARGIN AVG 3Y
N/A
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Atrium Therapeutics, Inc.
Market Cap
$136.67M
Operating Margin
-410.23%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$136.57M
Operating Margin
-34.07%
TTM Avg
-27.91%
3Y Avg
-72.83%
5Y Avg
-67.42%
Market Cap
$137.80M
Operating Margin
-3.66%
TTM Avg
-13.20%
3Y Avg
-25.26%
5Y Avg
-22.69%
Market Cap
$139.04M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-4081.44%
5Y Avg
-3115.66%
Market Cap
$139.47M
Operating Margin
-221.72%
TTM Avg
-110.86%
3Y Avg
-55.43%
5Y Avg
-36.95%
Market Cap
$139.84M
Operating Margin
-102.41%
TTM Avg
-243.38%
3Y Avg
-183.77%
5Y Avg
-176.77%
Market Cap
$132.03M
Operating Margin
-9.35%
TTM Avg
-5.78%
3Y Avg
-14.39%
5Y Avg
-45.18%
Market Cap
$131.21M
Operating Margin
-7.85%
TTM Avg
-2.10%
3Y Avg
-0.51%
5Y Avg
4.29%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | $136.67M | -410.23% | N/A | N/A | N/A |
| Organigram Global Inc. (OGI)vs › | $136.57M | -34.07% | -27.91% | -72.83% | -67.42% |
| KORU Medical Systems, Inc. (KRMD)vs › | $137.80M | -3.66% | -13.20% | -25.26% | -22.69% |
| Immuneering Corporation (IMRX)vs › | $139.04M | 0.00% | 0.00% | -4081.44% | -3115.66% |
| Alpha Cognition Inc (ACOG)vs › | $139.47M | -221.72% | -110.86% | -55.43% | -36.95% |
| Sutro Biopharma, Inc. (STRO)vs › | $139.84M | -102.41% | -243.38% | -183.77% | -176.77% |
| Freenome, Inc. (FRNM)vs › | $133.45M | N/A | N/A | N/A | N/A |
| LifeMD, Inc. (LFMD)vs › | $132.03M | -9.35% | -5.78% | -14.39% | -45.18% |
| AirSculpt Technologies, Inc. (AIRS)vs › | $131.21M | -7.85% | -2.10% | -0.51% | 4.29% |
| Health Catalyst, Inc. (HCAT)vs › | $130.79M | -11.60% | -17.18% | -31.98% | -39.70% |
Gross Margin
97.9%
Operating Margin
-410.2%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -752.93% |
| 2026-03-31 | -88.01% |
| 2025-12-31 | -5591.97% |
| 2025-09-30 | 0.00% |
